• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.6787 -0.0225 (-3.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
March 16, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
March 11, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
March 04, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
March 02, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
February 17, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Santa’s Rally: CMCT, SURG, SIDU, MYSE, AZI – Stocks Under $5 to Watch Now – More Inside
December 22, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
December 17, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
December 15, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
December 08, 2025
Via ACCESS Newswire
News headline image
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
December 01, 2025
Via ACCESS Newswire
News headline image
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
December 01, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
November 10, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
October 29, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
October 06, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Present at Investor Conferences and BPI East
September 04, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
August 05, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
July 31, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
July 31, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
July 30, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
July 02, 2025
From Dyadic Applied BioSolutions
Via Business Wire
News headline image
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
June 02, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
May 01, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Present at World Vaccine Congress | Washington
April 16, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside
April 01, 2025
Via AB Newswire
News headline image
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
March 25, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant to Advance Global Vaccines & Therapeutics with C1 Fungal Platform – More Stocks Inside
March 24, 2025
Via AB Newswire
News headline image
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
March 20, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
March 12, 2025
From Dyadic International, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap